Citations for
1ZNF501, ZNF502, TMEM158, SACM1L, SLC6A20, CLEC3B, FYCO1, C3CER1
Evolutionarily plastic regions at human 3p21.3 coincide with tumor breakpoints identified by the elimination test.
Darai E, Kost-Alimova M, Kiss H, Kansoul H, Klein G, Imreh S.
Genomics 86(1):1-12. 2005
The plasminogen binding site of the C-type lectin tetranectin is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and lysine.
Graversen JH, Lorentsen RH, Jacobsen C, Moestrup SK, Sigurskjold BW, Thogersen HC, Etzerodt M.
J Biol Chem 273(44):29241-6 1998
Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro.
Wewer UM, Iba K, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, Kuang W, Engvall E, Albrechtsen R.
Dev Biol 200(2):247-59 1998
Assignment of the gene for human tetranectin (TNA) to chromosome 3p22-->p21.3 by somatic cell hybrid mapping.
Durkin ME, Naylor SL, Albrechtsen R, Wewer UM.
Cytogenet Cell Genet 76(1-2):39-40. 1997
[Tetranectin, a plasma and tissue protein--a prognostic marker of breast and ovarian cancer].
Hogdall CK, Christensen L, Clemmensen I.
Ugeskr Laeger 156(42):6190-5. Review. Danish 1994
Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein.
Fuhlendorff J, Clemmensen I, Magnusson S.
Biochemistry 26(21):6757-64 1987